Monday October 26, 2020

Falling off the patent cliff

Ireland's reliance on big pharma means the expiration of various drugs patents will hit the country's revenues hard, write Ian Kehoe and Colette Sexton.

9th June, 2012
A pharmacist for online drugs retailer holding boxes of Pfizer's cholesterol drug Lipitor, which has come off patent. Photo: Provision/Bloomberg

In isolation, the decision by the global pharmaceutical giant Pfizer to shed 177 jobs at its two Cork plants is hardly a body blow to Ireland.

After all, the figure represents less than 5 per cent of its Irish workforce, and the pharma giant is still ploughing investment money into its other Irish plants.

But the reason behind the job losses raises profound questions about Ireland's reliance on big pharma.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 9 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 5 years ago